(BPMC) Blueprint Medicines BollingerBands charts technical analysis
(BPMC) Blueprint Medicines BollingerBands charts technical analysis BollingerBands analysis of Blueprint Medicines | Buy/Sell Blueprint Medicines
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 2800840
| Date | Closing Price | Open | High | Low | Volume |
| 11 Fri Jul 2025 | 129.30 | 129.32 | 129.35 | 129.00 | 3.57 Mn |
| 10 Thu Jul 2025 | 129.33 | 129.49 | 129.49 | 129.23 | 5.984 Mn |
| 09 Wed Jul 2025 | 128.55 | 128.47 | 128.58 | 128.35 | 2.997 Mn |
| 08 Tue Jul 2025 | 128.40 | 128.37 | 128.78 | 128.31 | 2.959 Mn |
| 07 Mon Jul 2025 | 128.40 | 128.31 | 128.44 | 128.21 | 1.938 Mn |
| 03 Thu Jul 2025 | 128.35 | 128.25 | 128.40 | 128.20 | 1.35 Mn |
| 02 Wed Jul 2025 | 128.20 | 128.35 | 128.45 | 128.20 | 2.318 Mn |
| 01 Tue Jul 2025 | 128.34 | 128.18 | 128.52 | 128.16 | 2.595 Mn |
| 30 Mon Jun 2025 | 128.18 | 128.30 | 128.32 | 128.08 | 2.35 Mn |
| 27 Fri Jun 2025 | 128.11 | 128.24 | 128.28 | 128.06 | 2.989 Mn |
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.65 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
BollingerBands charts
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.65 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.